PMID- 28507833
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231112
IS  - 2168-8184 (Print)
IS  - 2168-8184 (Electronic)
IS  - 2168-8184 (Linking)
VI  - 9
IP  - 4
DP  - 2017 Apr 13
TI  - Does Hemodynamic-Guided Heart Failure Management Reduce Hospitalization? A 
      Systematic Review.
PG  - e1161
LID - 10.7759/cureus.1161 [doi]
LID - e1161
AB  - Heart failure (HF) is a pressing health concern as the expense of hospitalization 
      financially burdens the health care system. Hemodynamic monitoring has the 
      potential to detect increases in intracardiac filling pressures weeks before 
      clinical deterioration; hence, preliminary findings of volume overload with the 
      use of these devices may prevent the progression of disease and lead to a 
      reduction in HF-associated hospitalizations. We extensively searched PubMed, Ovid 
      SP, Embase, and Cochrane databases to identify all the possible studies that 
      assess the effect of hemodynamic monitoring on hospitalizations in HF patients. 
      The main outcomes considered were the rate of HF hospitalization, mortality, 
      quality of life, and improvement in New York Heart Association (NYHA) 
      functional class in the monitored group. Seven studies met all the eligibility 
      criteria and were incorporated in our systematic review. Out of the seven studies 
      we reviewed, three studies inserted the sensor in the pulmonary artery, three in 
      the right ventricle, and only one in the left atrium. On an average, the single 
      study on the left atrium showed the highest reduction (59.0%) in HF 
      hospitalization followed by the pulmonary artery (56.3%) and right ventricle 
      (31.0%), respectively. Our systematic review demonstrates that the use of 
      hemodynamic sensors in HF patients helps to reduce HF-related hospitalizations. 
      Therefore, a combination of outpatient monitoring via the use of hemodynamic 
      sensors and fluid management is needed to reduce HF hospitalizations and improve 
      outcomes in HF patients.
FAU - Minhas, Abdul M
AU  - Minhas AM
AD  - Internal Medicine, Orange Park Medical Center.
FAU - Ahmed, Saba
AU  - Ahmed S
AD  - Medical Student, Dow University of Health Sciences (DUHS), Karachi, Pakistan.
FAU - Khan, Muhammad S
AU  - Khan MS
AD  - Internal Medicine, John H Stroger J. Hospital of Cook County.
FAU - Fatima, Kaneez
AU  - Fatima K
AD  - Civil Hospital, Dow University of Health Sciences (DUHS), Karachi, Pakistan.
FAU - Anwar, Muhammad N
AU  - Anwar MN
AD  - Internal Medicine, Orange Park Medical Center.
FAU - Constantin, Jonathan
AU  - Constantin J
AD  - Cardiology, Orange Park Medical Center.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170413
PL  - United States
TA  - Cureus
JT  - Cureus
JID - 101596737
PMC - PMC5429151
OTO - NOTNLM
OT  - heart failure
OT  - hospitalization
OT  - implantable hemodynamic sensors
COIS- The authors have declared that no competing interests exist.
EDAT- 2017/05/17 06:00
MHDA- 2017/05/17 06:01
PMCR- 2017/04/13
CRDT- 2017/05/17 06:00
PHST- 2017/05/17 06:00 [entrez]
PHST- 2017/05/17 06:00 [pubmed]
PHST- 2017/05/17 06:01 [medline]
PHST- 2017/04/13 00:00 [pmc-release]
AID - 10.7759/cureus.1161 [doi]
PST - epublish
SO  - Cureus. 2017 Apr 13;9(4):e1161. doi: 10.7759/cureus.1161.